DBV Technologies ADR [DBVT] stock is trading at $17.98, down -1.69%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The DBVT shares have gain 4.78% over the last week, with a monthly amount glided 35.80%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
DBV Technologies ADR [NASDAQ: DBVT] stock has seen the most recent analyst activity on December 15, 2025, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $42. Previously, Guggenheim started tracking the stock with Buy rating on December 03, 2025, and set its price target to $35. Societe Generale upgraded its rating to a Buy. Goldman downgraded its rating to a Sell. Goldman downgraded its rating to Neutral for this stock on May 10, 2022, and downed its price target to $1.50. In a note dated September 14, 2021, Societe Generale upgraded a Buy rating on this stock.
DBV Technologies ADR [DBVT] stock has fluctuated between $2.74 and $21.50 over the past year. Currently, Wall Street analysts expect the stock to reach $37.33 within the next 12 months. DBV Technologies ADR [NASDAQ: DBVT] shares were valued at $17.98 at the most recent close of the market. An investor can expect a potential return of 107.62% based on the average DBVT price forecast.
Analyzing the DBVT fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -52.19%, Pretax Profit Margin comes in at -52.35%, and Net Profit Margin reading is -52.4%. To continue investigating profitability, this company’s Return on Assets is posted at -0.85, Equity is -2.87 and Total Capital is -1.3. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.56 points at the first support level, and at 17.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.34, and for the 2nd resistance point, it is at 18.70.
Ratios To Look Out For
For context, DBV Technologies ADR’s Current Ratio is 1.80. Further, the Quick Ratio stands at 1.80, while the Cash Ratio is 2.09.
Transactions by insiders
Recent insider trading involved Mohideen Pharis, Chief Medical Officer, that happened on Nov 20 ’25 when 6496.0 shares were sold. Chief Medical Officer, Mohideen Pharis completed a deal on Nov 21 ’25 to sell 1624.0 shares. Meanwhile, Chief Medical Officer Mohideen Pharis sold 464.0 shares on Jul 29 ’25.
